Dr Symeonides is a Medical Oncologist and Senior Clinical Lecturer at the Institute of Genetics and Cancer (University of Edinburgh) and at the linked Edinburgh Cancer Centre (NHS Lothian); he also has a Pharmaceutical Medicine role in CRUK’s Centre for Drug Development. After clinical training in the UK (Cambridge, Edinburgh), Australia (Melbourne) & New Zealand (Christchurch), and research in academia, clinic & industry, he now leads the Edinburgh Experimental Cancer Medicine Centre, where he provides the link between Edinburgh’s laboratory discoveries and their clinical development. In the clinic, he runs the Edinburgh Phase I Cancer Trials Unit and recently stepped down from a specialty interest in renal cancer to take on an increased Medical Advisor role in CRUK’s Centre for Drug Development. His research spans cytotoxic, small molecule, metabolic and even psychological therapies, but his main focus is immunotherapies, where he is the clinical lead for the Edinburgh Cancer Immunology network.
